Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration

AUTHOR GROUP

doi:https://doi.org/10.1097/QAD.0b013e3283480144

Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration

AUTHOR GROUP

Research output: Contribution to journal › Article › Academic › peer-review

34 Citations (Scopus)

Abstract

We evaluated hepatitis C virus (HCV) treatment and the effect of treatment duration (24 versus 48 weeks) on treatment outcome among 50 HIV-infected men who have sex with men with acute HCV infection in Amsterdam. Overall sustained virological response (SVR) rate was 76%. Treatment duration was not significantly associated with SVR (adjusted odds ratio = 2.32; 95% confidence interval 0.39-13.97), suggesting that 24-week treatment may be sufficient for acute HCV infection in HIV-coinfected patients

Original language	English
Pages (from-to)	1333-1336
Journal	AIDS (London, England)
Volume	25
Issue number	10
DOIs	https://doi.org/10.1097/QAD.0b013e3283480144
Publication status	Published - 2011

Access to Document

https://doi.org/10.1097/QAD.0b013e3283480144

Cite this

@article{27b28ece20f441ebb62c021a43350207,

title = "Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration",

abstract = "We evaluated hepatitis C virus (HCV) treatment and the effect of treatment duration (24 versus 48 weeks) on treatment outcome among 50 HIV-infected men who have sex with men with acute HCV infection in Amsterdam. Overall sustained virological response (SVR) rate was 76%. Treatment duration was not significantly associated with SVR (adjusted odds ratio = 2.32; 95% confidence interval 0.39-13.97), suggesting that 24-week treatment may be sufficient for acute HCV infection in HIV-coinfected patients",

author = "Lambers, {Femke A. E.} and Kees Brinkman and Janke Schinkel and Spijkerman, {Ingrid J. B.} and Richard Molenkamp and Coutinho, {Roel A.} and Maria Prins and {van der Meer}, {Jan T. M.} and {AUTHOR GROUP} and H. Reesink and {van Baarle}, D. and C. Smit",

year = "2011",

doi = "https://doi.org/10.1097/QAD.0b013e3283480144",

language = "English",

volume = "25",

pages = "1333--1336",

journal = "AIDS (London, England)",

issn = "0269-9370",

publisher = "Lippincott Williams and Wilkins",

number = "10",

}

TY - JOUR

T1 - Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration

AU - Lambers, Femke A. E.

AU - Brinkman, Kees

AU - Schinkel, Janke

AU - Spijkerman, Ingrid J. B.

AU - Molenkamp, Richard

AU - Coutinho, Roel A.

AU - Prins, Maria

AU - van der Meer, Jan T. M.

AU - AUTHOR GROUP

AU - Reesink, H.

AU - van Baarle, D.

AU - Smit, C.

PY - 2011

Y1 - 2011

N2 - We evaluated hepatitis C virus (HCV) treatment and the effect of treatment duration (24 versus 48 weeks) on treatment outcome among 50 HIV-infected men who have sex with men with acute HCV infection in Amsterdam. Overall sustained virological response (SVR) rate was 76%. Treatment duration was not significantly associated with SVR (adjusted odds ratio = 2.32; 95% confidence interval 0.39-13.97), suggesting that 24-week treatment may be sufficient for acute HCV infection in HIV-coinfected patients

AB - We evaluated hepatitis C virus (HCV) treatment and the effect of treatment duration (24 versus 48 weeks) on treatment outcome among 50 HIV-infected men who have sex with men with acute HCV infection in Amsterdam. Overall sustained virological response (SVR) rate was 76%. Treatment duration was not significantly associated with SVR (adjusted odds ratio = 2.32; 95% confidence interval 0.39-13.97), suggesting that 24-week treatment may be sufficient for acute HCV infection in HIV-coinfected patients

U2 - https://doi.org/10.1097/QAD.0b013e3283480144

DO - https://doi.org/10.1097/QAD.0b013e3283480144

M3 - Article

C2 - 21516025

SN - 0269-9370

VL - 25

SP - 1333

EP - 1336

JO - AIDS (London, England)

JF - AIDS (London, England)

IS - 10

ER -